.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Medtronic India recently introduced the groundbreaking PulseSelect system to the Indian healthcare market. This innovative technology brings Pulsed Field Ablation to local electrophysiologists for treating atrial fibrillation (AFib). Consequently, patients suffering from irregular heartbeats can now access a safer treatment pathway. Specifically, this next-generation device targets pulmonary veins with high precision, which significantly lowers stroke risks.
Atrial fibrillation currently affects over seven million people in India, creating a massive public health burden. Furthermore, many cases remain underdiagnosed because mild or intermittent symptoms often go unnoticed. If clinicians leave AFib untreated, patients face severe risks of stroke and heart failure. Therefore, continuing medical innovation is essential to strengthen the overall cardiac care ecosystem.
Traditional therapies like radiofrequency ablation and cryoablation rely on extreme heat or extreme cold. However, these thermal energies carry an inherent risk of damaging surrounding healthy tissues. In contrast, Pulsed Field Ablation utilizes short, high-voltage electrical pulses to isolate the pulmonary veins. Additionally, this non-thermal mechanism selectively targets cardiac cells while sparing critical structures like the esophagus and phrenic nerve. Consequently, the procedure offers an exceptional safety profile and supports a smoother recovery.
Electrophysiologists across India have welcomed this technological advancement. For example, prominent hospitals like Kauvery Hospital in Chennai have already launched specialized programs to integrate these advanced platforms. Moreover, clinical data from global trials confirms that the system maintains a high rate of procedural efficiency. As a result, physicians can perform these procedures faster while optimizing laboratory workflows. Ultimately, this launch provides Indian clinicians with a powerful tool to enhance precision and improve long-term patient outcomes.
Q1: What is Pulsed Field Ablation and how does it work?
Pulsed Field Ablation is a next-generation cardiac treatment. Indeed, it uses short electrical pulses instead of extreme thermal energy to isolate abnormal tissues. Specifically, this non-thermal process targets problematic cardiac cells through electroporation. Consequently, this selective approach avoids damaging nearby critical structures.
Q2: Why is the launch of the PulseSelect system in India significant?
Atrial fibrillation affects millions of people in India, which substantially increases stroke risks. However, the condition remains heavily underdiagnosed across the country. Therefore, introducing this advanced technology provides local physicians with safer and more precise tools.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Medtronic has introduced its innovative PulseSelect Pulsed Field Ablation (PFA) system in India. This next-generation, non-thermal cardiac ablation technology targets atrial fibrillation, reducing tissue damage risks and offering a safer, faster treatment option to help prevent strokes across the country.
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
